GVK Biosciences is the latest Indian firm to come under international scrutiny over quality issues.
The joint drug-discovery project of multinational pharma firm Wyeth and GVK Biosciences will fully take off within a month's time, following the establishment of a dedicated discovery chemistry research laboratory.
Germany's drug regulator has banned the sale of 80 generic medicines with immediate effect on the grounds that their clinical trials conducted by India's pharmaceutical research company GVK Biosciences were "insufficient".
Indian pharma firms under European drug regulator's scanner.
Negotiators from were expected to meet in New Delhi on August 28.
G V Sanjay Reddy, vice chairman of the GVK Group, elaborates on his plans for the much-awaited Mumbai airport makeover.
I would focus on R&D, correct or fine tune the US strategy and look at inorganic growth routes
The European Medicines Agency's review is the second setback to Alkem Laboratories
Asian markets were trading mixed with the Nikkei gaining after the US dollar strengthened against the yen.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances